Goldberg Michael sold $1.1M of CDNA

Goldberg Michael sold 13,800 shares of CareDx, Inc. (CDNA) at an average of $79.15 ($78.32–$79.85, $1.09M total) across 3 trades on 2026-11-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Goldberg Michael
Published Nov 16, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDNA
Neutral
medium confidence
Mentioned
$CDNA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDNANeutralLow
01

Why it matters

This provides transparency on insider activity but does not indicate a new operational catalyst. The pre-arranged 10b5-1 plan suggests the trades were planned in advance, reducing the informational content.

02

Market read

For CDNA, the main tradable takeaway is modest sentiment noise from insider selling, likely outweighed by the lack of fundamental news.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, financing, or litigation, the fundamental signal is weak.

Relevance 5/10Novelty 5/10Timing: filed 2026-11-16, covering sales dated 2026-11-12

Background

The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA), reported by director Michael Goldberg.

Company-level read

Ticker impact

$CDNANeutralMedium confidence
Context

CareDx director Michael Goldberg sold 13,800 shares in an open-market transaction under a pre-arranged 10b5-1 plan, totaling about $1.09M.

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than fundamentals-driven.

Evidence & confidence

The filing is a primary Form 4 disclosure, but it is an open-market sale by a director executed under a pre-arranged 10b5-1 plan, which typically dampens inference about near-term company outlook.

Market effects

No clear sector read-through; this is an individual insider transaction rather than a company operating or regulatory update.

None.

None.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish information.

Key entities

  • CareDx, Inc.

    Company whose director insider sale is disclosed on Form 4.

  • Michael Goldberg

    Director who sold 13,800 shares in open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

Futures Rise As CoreWeave Calms Debt Jitters, Sparking AI Rebound; Oil Jumps On Hormuz Mines

US futures rise as CoreWeave (CRWV) boosts its revenue forecast, easing debt concerns. AI sector gains momentum with reports of Anthropic's potential $1.5T IPO and OpenAI's $10B quarterly revenue. Nasdaq futures recover Tuesday's losses, while Treasuries near 5% on 10Y. Oil jumps on Strait of Hormuz tensions. CoreWeave shares up 15% premarket. NVDA +5.1%, TSLA +2%, GOOGL +1.2%.

$CDNALow

Why CareDx Stock Soared Today

CareDx (CDNA) shares rose 22% after Q3 revenue surged 39% YoY to $139M, driven by 65% growth in testing services. Testing volumes increased 51% to 75,900, aided by the Naveris acquisition. EBITDA doubled to $30M. The company raised full-year revenue guidance to $525M and adjusted EBITDA targets to $90M-$100M, citing growing interest in precision medicine diagnostics.

$CDNAHighAI 8/10

CareDx Soars 20% on Big Q3 Beat and Guidance Raise

CareDx's shares rose 20% after Q3 revenue increased 39% to $139M, surpassing expectations. The company raised 2026 revenue guidance to $520M-$530M. Adjusted EBITDA doubled to $30M. Natera, a competitor, reports next week, which may indicate market growth or share shifts.